Clinical trials
Obesity trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 15 |
| Unknown status | 10 |
| Not yet recruiting | 8 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 13 |
| Universidade do Porto | 9 |
| Sanofi | 4 |
| Faculdade de Motricidade Humana | 3 |
| Amgen | 2 |
| Eli Lilly and Company | 2 |
| Harokopio University | 2 |
| Hospital de Sao Sebastiao | 2 |
| Technical University of Lisbon | 2 |
| Unidade Local de Saúde de Coimbra, EPE | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 67 |
| Overweight | 19 |
| Diabetes Mellitus, Type 2 | 10 |
| Weight Loss | 4 |
| Dyslipidemias | 3 |
| Hypertension | 3 |
| Pediatric Obesity | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes, Gestational | 2 |
| Fatty Liver | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.